Digital Health Seed Deals
The following companies look promising to us and have just started raising money. They have been selected based on a number of criteria, including the founders’ previous experiences, the sector they’re in, existing traction, other investors, and more. If you act soon, you may be up for the big exit.
Headquarters: Cambridge, United Kingdom
Funding Amount: £3.75M
worth £2.5M was raised
on February 1, 2022.
Select investors: Nina Capital, APEX Ventures, University of Cambridge Enterprise, Parkwalk Advisors, Innovate UK
University of Cambridge technology spin-out Zetta Genomics is a leader in large-scale genomic data management for precision medicine. It is employing big data technology and best practice security to leverage genomic data benefits while preserving data privacy. The company's flagship offering, the XetaBase platform, is a genomic data management technology that powers the discovery and delivery of precision medicine at scale. It was built on the open-source OpenCB platform, co-developed by Zetta's founder Ignacio Medina to allow researchers and clinicians to securely store, easily access and dynamically interrogate vast and increasing volumes of genomic data - on demand. The technology brings genome-enabled discovery, healthcare analytics and population research into the lab - and prognostics, diagnostics and therapeutics into the clinic. more »
Headquarters: Dallas, Texas, United States
Category: Women's Health
Funding Amount: $4M
worth $2M was raised
on November 16, 2022.
Select investors: True Wealth Ventures, SoGal Ventures, Portfolia, Mindshift Capital, Joyance Partners, Social Starts
Designed by doctors and psychologists, Rosy is the first-of-its-kind platform offering women a holistic approach to sexual health and wellness. Accessible through a mobile app, Rosy offers personalized Wellness Plans that bring together an evidence-based, guided path to sexual wellness - created by experts to help users meet their unique goals, on their schedule. It also includes anonymous spaces for coaching and community to connect with sex experts and other members. more »
Headquarters: Tel Aviv, Israel
Category: Neurological Care
Funding Amount: $5.5M
on October 28, 2021.
Select investors: MS&AD Ventures, Matias Ventures, Tuesday Capital, Operator Partners, Kli Capital, VSC Ventures
NeuraLight is building an AI-driven platform to accelerate and improve drug development, monitoring, and care for patients with neurological disorders using information captured with a standard smartphone or webcam. The company's vision is a world where neurological disorders can be prevented, diagnosed, and treated effectively, and people live longer, healthier lives. more »
Headquarters: New York, New York, United States
Category: Neurological Care
Funding Amount: $2.2M
on February 2, 2022.
Select investors: Pear VC, Norwest Venture Partners, Global Founders Capital, Index Ventures, Next Play Ventures
Neura Health is a virtual neurology clinic. It is on a mission to improve the access and quality of neurological care - increase convenience, better outcomes, and lower costs. The company has developed a platform that connects patients to neurologists, with in-built neurology-specific symptom monitoring and condition-specific diagnostic tests. These include cognitive exams, psychomotor tests, and standard assessments. Neura Health's platform also has HIPAA-compliant text messaging and video visits, with a care concierge service to help patients with their various needs. more »
Headquarters: London, United Kingdom
Category: Remote Monitoring
Funding Amount: $3.3M
on September 15, 2021.
Select investors: Giant Ventures, Speedinvest
Doccla is changing healthcare by building what it calls the virtual hospital ward. The company partners with caregivers to take patients out of hospitals and monitor them remotely using medical class IoT devices. As a result, Doccla enables early hospital discharge, while avoiding readmission and freeing up hospital capacity. Already, several NHS entities have selected Doccla's virtual ward services, with example patient groups including COPD, Covid-19 and heart. more »